Alumni

Dr.Vajja Krishna Rao

• Batch - 2017-2022

• Current position - Postdoctoral Researcher at the University of Health Network, Toronto

• Thesis Title - Synthesis of triazole-sulfonamide and benzodithiazinedioxide-guanidine based new molecular motifs as potential anticancer agents

Dr. Divine P. Daniel

• Batch - 2016-2021

• Current position - Medical Science - Employee in Govt. of Kerala

• Thesis Title - Synthesis of Ellipticine-Structural Modulated Analogs as Potential Antiproliferative Agents

Dr. Gulshan Kumar

• Batch - 2016-2021

• Current designation - Postdoctoral Scholar at IIT Gandhinagar

• Thesis Title - Synthesis of N-Fused Heterocyclic Analogs of Flavonoids and Bioevaluation Studies towards Discovery of Anticancer Agents 

     Dr. Preeti

• Batch - 2015-2020

• Current designation - Principal Scientist in Biocon Biologics Limited

• Thesis Title - Synthesis and biological evaluation of pyrimidinetrione and its furo-fused derivatives as topoisomerase II inhibitors

     Dr. Shailendra Sisodiya 

• Batch - 2014-2019

• Current designation - Lead Investigator 2, Alembic Pharmaceuticals Limited 

• Thesis Title - Synthesis and bio-evaluation studies of new  molecular motifs as potential topoisomerase II inhibitors 

     Dr. Neha Hura  

• Batch - 2012-2017

• DST-INSPIRE Fellow

• Current designation - Strategic Project Manager, Novartis Canada.

• Thesis Title - Combretastatin A-4 Inspired Heterocyclic Compounds as Antitubulins: Synthesis and Bio-Evaluation Studies

     Dr. Garima Priyadarshani  

• Batch - 2011-2016

• Current designation - Senior Scientist II, SchrÖdinger

• Thesis Title - Scaffold Hopping of Flavonoids: Synthetic Exploration and Studies of Topoisomerase II– Targeting Anticancer Activities

     Dr. Meenu Saini

• Batch - 2014-2019

• CSIR-UGC NET Fellow

• Current designation - Research Manager at Sun Pharmaceutical Industries Limited Gurugram 

• Thesis Title - Synthesis and Biological Studies of Pyridine N-fused Heterocyclic Derivatives as Topoisomerase II Inhibitors

     Dr. Suyog Madhav Amrutkar 

• Batch - 2012-2017

• Current designation - Manager-Scientific Intelligence Group, Amneal Pharmaceutical Ltd. Ahmedabad 

• Thesis Title - Investigation of fused N-heterocyclic compounds as potential hTopo-II inhibitors 

  Dr. Neha Tripathi 

• Batch - 2012-2017

•  CSIR-NET Fellow, DBT-BINC Qualified 

• Current designation - Research Scientist in Drug discovery team, Aqemia, Paris, Île-de-France, France

• Thesis Title - Pharmacoinformatics Analysis of Human Topoisomerase IIα: Identifying New Opportunities in Anticancer Drug Design 

 Dr. Vikas Chaudhary

• Batch - 2009-2014

•  CSIR-NET Fellow

• Thesis Title - Novel Heterocyclic-Condensed Purines: Synthetic Exploration and Bio-evaluation Studies

     Dr. Maneesh Kashyap  

• Batch - 2008-2013

• Current designation - Scientist - Project Management (Research & Planning) - NIPER SAS Nagar 

• Thesis Title - Synthesis and Biological Evaluation of Indenoindolones and their Derivatives as Topoisomerase II Inhibitors” 

    Dr. Ashish Baviskar   

• Batch - 2009-2013

• Current designation - Senior Research Scientist, Innovation and Development, Abbott Healthcare Pvt. Ltd.  

• Thesis Title - Synthesis, Biological Evaluation and Pre-formulation Studies of N-Fused Imidazole Derivatives as Topoisomerase II  Inhibitors

     Dr. Chetna (Madaan) Arora 

• Batch - 2007-2011

• Current designation - Associate Director of Product Management at IQVIA 

• Thesis Title - Development and Application of Multicomponent Reactions in Synthesis of Heterocyclic Compounds as Potential Topoisomerase II Inhibitors. 

Former M.S. (Pharm.) Students

Mr. Abhishek Sharma

• Batch - 2021-2023

• Current designation - Junior Analyst at Evalueserve SEZ India

• Thesis Title - To explore ylide chemistry in annulation reaction towards synthesis of Oxa-heterocycles 

Mr. Brijesh Prajapati

• Batch - 2021-2023

• Thesis Title - To synthesize benzodithiazine-1,1-dioxide-3-amines as potential DNA polymerase inhibitors

Mr. Jagroop Singh

• Batch - 2021-2023

• Current designation- Incoming Ph.D. student at Newcastle University, UK (Spring 2024)

• Thesis Title - Development of method for synthesis of thiazolo-diazaphosphinine-5-oxide derivatives as potential anticancer agents

Mr. Rakesh Kumar Singh

• Batch - 2021-2023

• Thesis Title - Synthesis of aryl/heteroaryl substituted fused arylidene imidazolones as potential anticancer agents

Ms. Santhanalaxmi Kumaresan

• Batch - 2021-2023

• Thesis Title - Synthesis of Scaffold-hopped analogues of Tryptanthrin as potential anticancer agents

Mr. Soumyadeep Patranabis

• Batch - 2021-2023

• Current designation - Research Trainee at Enveda Biosciences 

• Thesis Title -  Development of method for synthesis of Pyrido-fused diazaphoshinine-4-oxide derivatives as potential anticancer agents

Mr. Umesh Patil 

• Batch - 2021-2023

• Current designation - Technical Trainee at GRANULES INDIA LTD.

• Thesis Title - To explore the reaction of nitrile-stabilized quaternary ammonium ylide in the synthesis of N-heterocyclic scaffold

Mr. Vishal Khawshi

• Batch - 2021-2023

• Current designation - Executive in Regulatory Affairs and Business continuity, SUN Pharma

• Thesis Title - Synthesis of various pyrimidinone derivatives as anticancer agents

Ms. Yasaswini Saladi

• Batch - 2021-2023

• Current designation- Associate Analyst at Global Data

• Thesis Title - Synthesis of Trimethoxyphenyl azole-fused pyrimidine-5-one derivatives as tubulin polymerization inhibitors

Mr. Gautam Sahni 

• Batch - 2020-2022

• Current designation - Business Analyst at Evalueserve SEZ India

• Thesis Title - Synthesis of Pyrido-fused diazaphosphinine-4-oxide derivatives as potential anticancer agents

Ms. Mohini Singh

• Batch - 2020-2022

• Current designation -QC officer at Biocon Biologics Ltd 

• Thesis Title -Synthesis of Arylidene-imidazo[1,2-a]pyridin-3-one derivatives as potential anticancer agents

Mr. Nabajyoti Patra 

• Batch - 2020-2022

• Current designation -Pursuing PhD at NIPER S.A.S NAGAR

• Thesis Title -Synthesis of 2-Arylpyrido[1,2-a]pyrimidin-4-one derivatives as potential anticancer agents 

Ms. Nibedita Roy 

• Batch - 2020-2022

• Current designation - JRF  at NIPER S.A.S. NAGAR

• Thesis Title -Synthesis of Benzodithiazine-1,1-dioxide derivatives as potential DNA polymerase inhibitors

Mr. Prashant Mahadu Chavan 

• Batch - 2020-2022

• Current designation -Trainee DMPK at Sai Life Sciences Ltd

• Thesis Title -Synthesis of 3,7-diarylthiazolo [3,2-a] pyrimidin-5-one derivatives as potential anticancer agents

Mr. Rutvij Anil Pokale 

• Batch - 2020-2022

• Current designation -Senior Scientist at Biocon Biologics Ltd. 

• Thesis Title - Synthesis of arylidenefuro[2,3-d]pyrimidine-2,4,5- triones as potential topoisomerase II inhibitors 

Mr. Simranjit Singh Thind 

• Batch - 2020-2022

• Current designation - Self employed 

• Thesis Title -Synthesis of various amino/ether derivatives of 7-Aryl-thiazolopyrimidin-5-ones as potential anticancer agents 

Mr. Susmit Santosh Gogate 

• Batch - 2020-2022

• Current designation -Junior Associate - Scientific Writing at Indegene

• Thesis Title -Synthesis of Triazole-benzene-sulfonamide or sulfone derivatives as potential DNA Polymerase Inhibitors

Mr. Vishal Shesharam Tak 

• Batch - 2020-2022

• Current designation -Tech lead at Baxter Innovations & Business Solutions Pvt Ltd 

• Thesis Title -Synthesis of Arylidine-thiazolo-diazaphosphole-3-oxides as potential anticancer agents

Ms. Kuntala Dey

• Batch - 2019-2021

• Current designation - Graduate Student at UF College of Pharmacy, USA (Fall 2022) 

• Thesis Title in Master research (NIPER) - Synthesis of Arylmethylidine N-Fused- Azoloimidazolones as Potential Topoisomerase Ⅱ Inhibitors.

Mr. SANJAY C S 

• Batch - 2019-2021

• Current designation - Analyst at Regional Drug Testing Laboratory, Ernakulam, Kerala 

Ms. Ankita Jadhav

• Batch - 2019-2021

• Current designation - Scientist at Biocon Biologics Limited, Bangalore.

• Thesis Title -  Synthesis of Triaryl Alkenes: An Approach of Palladium-Catalysed Coupling Reaction of arylalkynes and arylboronic acid . 

Mr. Vijay Sanjaysinh Pardeshi 

• Batch - 2019-2021

• Current designation - Research Associate at Alkem Laboratories Ltd.

Ms. Riya

• Batch - 2019-2021

• Current designation - Officer, Analytical research and development, Akums Lifesciences limited Punjab 

Ms. Pallavi Saha

• Batch - 2019-2021

• Current designation - Ph.D Research Scholar at IIT-BHU (Varanasi).

Mr. Sayan Mondal

• Batch - 2018-2020

• Current designation - Patent Research Analyst at Stellarix Consultancy Services Ltd. 

• Thesis Title - Preparation of 2,3-Disubstituted/Functionalized Imidazo[1,2-a]pyridines

Ms. Palak Gupta

• Batch - 2018-2020

• Current designation - Graduate student, University of Florida 

Ms. Utkarsha Soundankar

• Batch - 2015-2017

• Current designation - Senior Research Analyst-Healthcare & Lifesciences, Frost & Sullivan

• Thesis Title - Investigation of Alternative Carbonylating Agents in the Synthesis of Heterocycles

Mr. Moksha Shah

• Batch - 2015-2017

• Current designation - Associate manager-GSC, Eli Lilly and Company 

• Thesis Title - Synthesis of 4-Hetero(Aryl) and 6-Trimethoxyphenyl substituted 3,4- Dihydropyrimidine-2(1H)-Thiones and Pyrimidine-2-Thiols as potential Tubulin  Polymerization Inhibitors

Mr. Maharudra Rambhau Dhakne

• Batch - 2015-2017

• Thesis Title - Development of method for 3-acylation of indoles

Mr. Pritam Giri

• Batch - 2015-2017

• Current designation - PhD student at Konkuk university, Seoul, South Korea 

• Thesis Title - Synthesis of 5-(3,4,5-trimethoxyphenyl)-2-aminoimidazoles with versatile quinoline substitutions as potential tubulin polymerization inhibitors

Mr. Darshan Rameshchandra Sheladiya

• Batch - 2010-2012

• Current designation - Jr. Executive, Wockhardt Ltd.

• Thesis Title - Synthesis of N-Fused Heterocyclic Analogs of Diindolylmethane as Potential Topoisomerase II Inhibitors

Mr. Ajay Chandgude 

• Batch - 2010-2012

• Current designation -Postdoctoral Research Fellow  Harvard University,   Dana-Farber Cancer Institute - Harvard Medical School 

• Thesis Title - Development of multicomponent reactions for the synthesis of Imidazoheterocycles: preparation of Zolpidem

Mr. Somnath Gulab Kandekar

• Batch - 2009-2011

• Current designation -Scientist, AC Immune SA 

• Thesis Title - Direct C-H bond activation of N-fused imidazoles 

Mr. Harshad Kamble 

• Batch - 2008-2010

• Current designation - Manager (IP), Abbott Healthcare 

• Thesis Title - Design and synthesis of heterocyclic compounds as a potential Topoisomerase II inhibitors 

Mr. Balmukund Thakkar 

• Batch - 2007-2009

• Current designation - Senior Chemist, Cambrex Karlskoga AB, Sweden 

• Thesis Title - Design and synthesis of 4-aminocinnolines as potential antimalarial agents